Home LiteratureArticle Details
PMID: 326665 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Capsule size of Cryptococcus neoformans: control and relationship to virulence.

Infection and immunity ·Vol. 16 ·No. 1 ·1977-04-00 ·Pages 129-35

Dykstra MA, Friedman L, Murphy JW

Abstract

Capsule size of five isolates of Cryptococcus neoformans was controlled by cultivation in media containing varying amounts of sugar. High concentrations of sugar (e.g., 16%) suppressed encapsulation whereas low concentrations (e.g., 1%) allowed maximal encapsulation. Suppression of capsule size was attributed at least in part to the increased osmolarity of the medium because a medium with low sugar concentration but having high osmolarity (by virtue of added sodium chloride) also produced cells having small capsules. The extent of control was more marked with certain of the isolates than with others. Mice were intravenously inoculated with cells of a single isolate cultivated so as to have either small or large capsules, and virulence was measured by comparing death rates. Results indicate that virulence after such an inoculation is a constant characteristic of an isolate and is not affected by size of the capsule of the cells in the inoculum.

MeSH Terms
Cryptococcus/pathogenicity Cryptococcus neoformans/growth & development,pathogenicity,ultrastructure Culture Media Virulence
Chemicals
Culture Media
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dykstra M A
Friedman L
Murphy J W
References (13)
13 references, click to expand
  1. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes.
    Mycologia. 1976 Jul-Aug;68(4):943-6 PMID: 790173
  2. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.
    Infect Immun. 1972 Apr;5(4):491-8 PMID: 4564677
  3. Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
    J Bacteriol. 1967 Nov;94(5):1480-3 PMID: 4862192
  4. An evaluation of various environmental factors affecting the propagation of Cryptococcus neoformas.
    Mycopathol Mycol Appl. 1968 Jul 12;35(2):81-90 PMID: 5686453
  5. Cryptococcus neoformans. I. Nonencapsulated mutants.
    J Bacteriol. 1967 Nov;94(5):1475-9 PMID: 6057803
  6. The isolation of Cryptococcus neoformans from pigeon nests; with remarks on the identification of virulent cryptococci.
    Am J Clin Pathol. 1957 Jun;27(6):652-63 PMID: 13444219
  7. Capsule synthesis by Cryptococcus neoformans.
    Trans N Y Acad Sci. 1958 May;20(7):623-48 PMID: 13556861
  8. Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.
    Proc Soc Exp Biol Med. 1959 Aug-Sep;101:773-7 PMID: 14417558
  9. Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies.
    J Bacteriol. 1962 Apr;83:926-8 PMID: 14454127
  10. [Capsular polyoside of a pathogenic fungus Torulopsis neoformans; relation to virulence].
    Ann Inst Pasteur (Paris). 1950 Dec;79(6):891-900 PMID: 14811117
  11. A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica).
    J Bacteriol. 1950 Feb;59(2):263-75 PMID: 15421955
  12. Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.
    Infect Immun. 1970 Jun;1(6):526-31 PMID: 16557771
  13. Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.
    Infect Immun. 1971 Feb;3(2):287-94 PMID: 16557967
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1977-04-00
Pages
129-35
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC421499
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]